UK authorisation
Androlabs receives UK authorisation for new Testavan presentation
September 4, 2026Androlabs, Testavan, UK authorisation, hypogonadism, testosterone
Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
